| NCT05955157 |
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma |
View |
| NCT00003157 |
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach |
View |
| NCT02237157 |
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer |
View |
| NCT04483726 |
Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA) |
View |
| NCT03745326 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients |
View |
| NCT00709826 |
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer |
View |
| NCT04985357 |
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs |
View |
| NCT06475326 |
Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer |
View |
| NCT06284226 |
An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients |
View |
| NCT04581876 |
The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer |
View |
| NCT02172976 |
Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma |
View |
| NCT06436976 |
The Effect of Probiotics ATG-F4 in Cancer Patients |
View |
| NCT00454376 |
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors |
View |
| NCT02560376 |
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis |
View |
| NCT06134960 |
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor |
View |
| NCT03205176 |
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas |
View |
| NCT01924260 |
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer |
View |
| NCT02230176 |
Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II |
View |
| NCT02368860 |
OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma |
View |
| NCT00005860 |
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum |
View |
| NCT01438476 |
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas |
View |
| NCT00501176 |
Preoperative Stent Study |
View |
| NCT04431076 |
Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes |
View |
| NCT06283576 |
Pancreatic Cancer Initial Detection Via Liquid Biopsy |
View |
| NCT01693276 |
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer |
View |
